Cargando…

Recovery from coma of a patient having acute progression of primary central nervous system lymphoma using tirabrutinib and methylprednisolone

Detalles Bibliográficos
Autores principales:	Satow, Takeshi, Horiguchi, Satoshi, Komuro, Taro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Brief Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7770517/ https://www.ncbi.nlm.nih.gov/pubmed/33409497 http://dx.doi.org/10.1093/noajnl/vdaa164

Ejemplares similares

ML-21 Tirabrutinib monotherapy for relapsed/refractory primary central nervous system lymphoma
por: Kobayashi, Keiichi, et al.
Publicado: (2020)

Histological verification of the treatment effect of tirabrutinib for relapsed/refractory primary central nervous system lymphoma
por: Okita, Yoshiko, et al.
Publicado: (2021)

ML-16 First clinical experience of administration of Tirabrutinib for the patients with newly diagnosed primary central nervous system lymphoma
por: Onodera, Sho, et al.
Publicado: (2021)

ML-9 TREATMENT OUTCOMES OF TIRABRUTINIB FOR RELAPSED AND REFRACTORY PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA IN A SINGLE INSTITUTE
por: Ohka, Fumiharu, et al.
Publicado: (2022)

Phase I/II study of tirabrutinib, a second-generation Bruton’s tyrosine kinase inhibitor, in relapsed/refractory primary central nervous system lymphoma
por: Narita, Yoshitaka, et al.
Publicado: (2020)

ML-05 One-year follow-up data of phase I/II study of tirabrutinib in patients with relapsed or refractory primary central nervous system lymphoma
por: Mishima, Kazuhiko, et al.
Publicado: (2020)

Caudal Cingulate Infarction Manifesting Astasia
por: Satow, Takeshi, et al.
Publicado: (2014)

Premorbid instrumental activities of daily living predicts discharge home following stroke
por: Satow, Takeshi, et al.
Publicado: (2020)

Intrathecal baclofen therapy for Lesch-Nyhan disease: illustrative case
por: Satow, Takeshi, et al.
Publicado: (2021)

Transcranial Direct Current Stimulation Improves Pusher Phenomenon
por: Yamaguchi, Takuya, et al.
Publicado: (2019)

Bing-Neel Syndrome Successfully Treated with Tirabrutinib
por: Oyama, Takashi, et al.
Publicado: (2022)

Waldenstrom Macroglobulinemia/Lymphoplasmacytic Lymphoma Associated with Nephrotic Syndrome during Hemodialysis, Treated Successfully with Tirabrutinib
por: Sekiguchi, Yasunobu, et al.
Publicado: (2022)

Refractory Primary Vitreoretinal Lymphoma Involving the Spinal Cord with a Temporary Complete Response to Tirabrutinib
por: Iizuka-Honma, Hiroko, et al.
Publicado: (2022)

ML-11 Tirabrutinib treatment for recurrent or refractory PCNSL
por: Ohka, Fumiharu, et al.
Publicado: (2021)

Two‐year outcomes of tirabrutinib monotherapy in Waldenström’s macroglobulinemia
por: Sekiguchi, Naohiro, et al.
Publicado: (2022)

Comparing indices of responsiveness for the Coma Near‐Coma Scale with and without pain items: An Exploratory study
por: Weaver, Jennifer A., et al.
Publicado: (2023)

Does Tigecycline Have a Place in Therapy for Rickettsial Infection of the Central Nervous System?
por: Mastroianni, Antonio, et al.
Publicado: (2022)

Phase 1b study of tirabrutinib in combination with idelalisib or entospletinib in previously treated B-cell lymphoma
por: Morschhauser, Franck, et al.
Publicado: (2020)

Impairment of bimanual in-phase movement during recovery from frontal lobe tumor surgery: a case report
por: Takada, Kozue, et al.
Publicado: (2023)

Intraventricular immune checkpoint inhibition with nivolumab in relapsed primary central nervous system lymphoma
por: Kaulen, Leon D, et al.
Publicado: (2022)

Mixed Pial-Dural Arteriovenous Malformation in the Anterior Cranial Fossa Mimicking Dural Arteriovenous Fistula
por: Maki, Yoshinori, et al.
Publicado: (2021)

Recovery from Diabetic Coma
Publicado: (1908)

Chill coma in the locust, Locusta migratoria, is initiated by spreading depolarization in the central nervous system
por: Robertson, R. Meldrum, et al.
Publicado: (2017)

Japan Coma Scale and the Disorientation of the Nervous System
por: Saeki, Soichiro, et al.
Publicado: (2023)

Anti-myelin-associated-glycoprotein neuropathy successfully treated with tirabrutinib
por: Yasuda, Hajime, et al.
Publicado: (2022)

The Impact of Tirabrutinib Monotherapy for Bing-Neel Syndrome in Waldenström's Macroglobulinemia
por: Sekiguchi, Naohiro
Publicado: (2022)

BTK mutations in patients with chronic lymphocytic leukemia receiving tirabrutinib
por: Jackson, Ross A., et al.
Publicado: (2023)

Progress in Diabetic Coma
Publicado: (1900)

Conditional relative survival in primary central nervous system lymphoma: a population-based study in the Netherlands
por: Dinmohamed, Avinash G, et al.
Publicado: (2020)

Severe hemodynamic depression after carotid artery stenting: The problem overcome with a transvenous temporary cardiac pacemaker
por: Fujii, Masako, et al.
Publicado: (2021)

Primary central nervous system lymphoma: Inter‐compartmental progression
por: Raval, Vishal, et al.
Publicado: (2022)

Structure of BTK kinase domain with the second-generation inhibitors acalabrutinib and tirabrutinib
por: Lin, David Y., et al.
Publicado: (2023)

Neuropsychological assessment through Coma Recovery Scale-Revised and Coma/Near Coma Scale in a sample of pediatric patients with disorder of consciousness
por: Frigerio, Susanna, et al.
Publicado: (2022)

Central Nervous System Progression/Relapse in Mature T- and NK-Cell Lymphomas
por: Bhansali, Rahul S., et al.
Publicado: (2023)

Complete recovery from an unusual cause of coma
por: Rovers, Jörgen M. P., et al.
Publicado: (2007)

ML-05 A CASE OF NEUROLYMPHOMATOSIS ARISED SECONDARILY FROM PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA
por: Horiguchi, Keishi, et al.
Publicado: (2019)

BAFF is produced by astrocytes and up-regulated in multiple sclerosis lesions and primary central nervous system lymphoma
por: Krumbholz, Markus, et al.
Publicado: (2005)

Bruton's tyrosine kinase (Btk) inhibitor tirabrutinib suppresses osteoclastic bone resorption
por: Ariza, Yuko, et al.
Publicado: (2019)

ML-17 Clinical usefulness of Tirabrutinib in recurrent PCNSL: single institute experience
por: Matsuura, Jin, et al.
Publicado: (2021)

Efficacy and Safety of Tirabrutinib and Idelalisib With or Without Obinutuzumab in Relapsed Chronic Lymphocytic Leukemia
por: Kutsch, Nadine, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_8l0rri7jrt5m6slbce1ci3c2pg